artificial intelligence

As part of its effort to stay ahead of new and emerging technologies, the U.S. Federal Communications Commission (FCC) will vote later this month on proposed rules to address the growing use of artificial intelligence (AI) in generating illegal robocalls.

A recent paper published in the Journal of Law and the Biosciences maps out how the introduction of artificial intelligence (AI)-based medical devices may challenge current regulatory requirements, including the European Union’s Medical Device Regulation (MDR).

Recognizing the growing deployment and use of AI-enabled technologies, the U.S. Food and Drug Administration has published a white paper on the use of AI in medical products and devices.

The goal line is in sight for legislators in the European Union (EU) in...

In a major regulatory development, the European Parliament has passed a draft law that...

As artificial intelligence (AI)-based technology and systems are more widely deployed, the U.S. National...

The U.S. Food and Drug Administration (FDA) has published its first list of authorized...

In the wake of its exit from the European Union, the United Kingdom is...

The Commission of the European Union (EU) has released a comprehensive proposal for a...

The U.S. Food and Drug Administration (FDA) has released its plan for regulating certain...